Kennedy’s SSRI rhetoric fuels distrust amid teen mental health crisis
While his war on vaccines may be getting more attention, health secretary Robert F. Kennedy Jr. is coming…
Novo Nordisk faces ‘must-win’ battle over U.S. Wegovy, Ozempic in 2026
Still life of the big three injectable prescription weight loss medicines. Ozempic, Victoza and Wegovy. (Photo by: Michael…
Eight Roads-backed PlasmaGen Bio snags funding, valuation nears $170 mn
Plasmagen Biosciences CEO Vivek Kamath PlasmaGen Biosciences, a biopharmaceutical company which counts investors such as Eight Roads Ventures…
Pharma’s ‘Dr. Optimistic’ is worried about the industry’s future
In July 2006, The New York Times sent young reporter Alex Berenson to Pfizer to interview me about…
Nasal spray sold nationwide recalled. See impacted products.
Something you bought was just recalled. What does that mean? What happens when something you purchase is recalled?…
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)
Milestone Pharmaceuticals received U.S. Food and Drug Administration approval of CARDAMYST for the conversion of acute symptomatic episodes…
UnitedHealth Group releases results of independent audit
UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans |…
FDA voucher program has led to political interference in drug reviews, staffers say
WASHINGTON — A new program intended to fast-track drug reviews at the Food and Drug Administration is quickly…
Meta urged by state AGs to regulate weight loss drug ads
More than three dozen state attorneys general are urging Meta to better enforce its policies to thwart a…
Eli Lilly to build $6 billion Alabama manufacturing plant
Eli Lilly CEO David A. Ricks speaks at a press conference at Generation Park in Houston, Monday, Sept.…
Wegovy’s prices are going down, but they are ‘wildly different’ — and confusing – MarketWatch
Wegovy’s prices are going down, but they are ‘wildly different’ — and confusing MarketWatchGeneric drug companies rework pricing to…
Cancer patients to get greater access to drugs on NHS under UK-US pharma deal
The deal will mean British pharma products imported into the US will not face tariffs, in return for…